Trade Bayer ^BAYGn

Assessing Bayer (XTRA:BAYN) Valuation After Mixed Share Performance And Profit Recovery Hopes

Xabi Alonso Appointed Chelsea Manager on Four-Year Deal

Bayer Aktiengesellschaft Backs Crop Science Targets as Seed Pipeline Gains Momentum

Alonso deal nears - have your say

AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer

Bayer Introduces Midol® in Motion, Empowering Menstruators to Find PMS Relief Through Movement | Morningstar

Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study

Alembic Pharma Gets USFDA Nod for Prostate Cancer Drug

Bayer (XTRA:BAYN) Swings To €2.81 EPS Profit And Tests Long‑Running Bearish Narratives

Bayer Partners with Luke Bryan to Donate 1 Million Meals Through Feeding America® to Expand Access to Food and Nutrition in Rural Communities | Morningstar

Bayer's FarmRise app reaches 5 million users

Farm Hands on the Potomac: Adesina joins BGR Group, Newman departs IDFA for FCA, Trujillo joins NCBA

SAP Sapphire 2026: Credible Vision, Real Concentration Risk

Bayer AG (BAYRY) Q1 2026 Earnings Call Highlights: Strong Sales Growth Amidst Cash Flow Challenges

Investor sues after $150M San Antonio mixed-use project fizzles

Q1 2026 Bayer AG Earnings Call Transcript

European Markets Decline Amid Political Turmoil and Oil Price Surge

Stellarix Identifies Major Strategic Shifts as Agrochemical Leaders Bet on Integrated Solutions

European Markets Decline Amid Political Uncertainty and Earnings Reports

Bayer and the National Hospital of Obstetrics and Gynaecology sign deal to improve women"s healthcare

Bayer profit up on seed business but glyphosate sales struggle

Bayer Q1 Profit Jumps; Confirms Full-Year Outlook At Constant Currencies

Sowing Innovation: The Bayer and Microsoft 2026 Digital Ecosystem

Bayer, bp Sign Deal to Scale Biofuel Crop Production

Advances in diagnosing and treating diabetic retinopathy

A Look At Bayer (XTRA:BAYN) Valuation As Cardiac Amyloidosis Trial Hits Phase III Milestone

The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial

Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial

Is Bayer (XTRA:BAYN) Offering Opportunity After 54.3% One Year Share Price Gain?

Bayer Crop Science and bp partner to expand camelina market for biofuels

Corteva's Vylor Spinoff And Bayer Deal Reframe Valuation Story

Can India's rice farmers reap from US$30 million Amazon carbon credit deal?

Gossip: Leverkusen also keen on Esteve

Gossip: Leverkusen also keen on Eseteve

Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial

Bayer Reshapes Pharma And Crop Science With Perfuse Deal And bp Alliance

Investigational PET Tracer Iodine 124 Evuzamitide from Bayer Met Primary Endpoints in Phase III Study in Patients Suspected to Have Cardiac Amyloidosis | Morningstar

Protect Soil, Farming and Health from Adverse Impacts of Chemical Pesticides | Countercurrents

Bayer bets on mid-stage vision drug with $2.4 Bn Perfuse Therapeutics buyout

Avalo's IL-1 beta-targeting abdakibart scores in HS phase II | BioWorld

Bayer and bp Form Strategic Alliance to Jointly Scale Camelina as Intermediate Crop for Biofuels

Bayer to buy Perfuse Therapeutics in up to $2.45 billion deal

Bayer Buys US Drugmaker Perfuse for as Much as $2.45 Billion (1)

Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion | Morningstar

Bayer To Acquire Perfuse Therapeutics; Expands Ophthalmology Pipeline

Bayer to Acquire Perfuse Therapeutics to Complement Ophthalmology Pipeline | Morningstar

Bayer buying Perfuse for $300M up front in potential $2.45B deal | BioWorld

Cytokinetics Reports First Quarter 2026 Financial Results and Provides Business Update | Taiwan News | May. 6, 2026 04:05

Hurzeler expected to sign new Albion deal 'shortly' - Yahoo Sports

Analysis-Trump's Germany troop cuts show limits of NATO efforts to keep US on board - Yahoo News UK

U.S. Supreme Court divided by lawsuits over Roundup, cancer

Driving climate-smart agriculture: John Kanyingi's vision for East Africa's farmers

Assessing Bayer (XTRA:BAYN) Valuation After New OCEANIC STROKE Phase III Asundexian Data Spotlight

Is It Too Late To Consider Bayer (XTRA:BAYN) After A 59.8% One-Year Surge?

Consumer product safety recall roundup for May 1, 2026

Nearly 800K Afrin bottles recalled after faulty packaging causes child safety risk

Are there new products coming down the line?

Bayer recalls nearly 800,000 Afrin bottles over child safety risk | Fox Business

Nasal spray sold nationwide recalled by Bayer. See affected products

House strips MAHA-hated pesticide provisions from farm bill

Bayer backs Norwich Research Park global scale-up programme for agri-food biotech businesses

Regeneron Reports First Quarter 2026 Financial and Operating Results | Taiwan News | Apr. 29, 2026 18:30

Edmond Tapsoba nearing contract extension at Bayer Leverkusen

AOC Grills Trump Cabinet Member on Major 'Conflict of Interest' In Heated Hearing Exchange

Supreme Court Hears Case On How To Label Risks of Popular Weed Killer

Thousands of Roundup Lawsuits Hinge on Bayer's US Supreme Court Case

Bayer's strongest-ever pharma portfolio and promising pipeline drive future growth

European Markets Rise Amid Earnings Reports and Geopolitical Tensions

Supreme Court hears arguments on how to label risks of popular weedkiller | Fox News Video

Bayer outlines growth path to 2030 driven by AI and pharma innovation

Digital tools reshape Vietnam's agriculture

Dermal Mycosis Market Research Report 2025-2026 & 2035, Competitive Analysis of Bayer, Kenvue, Karo Healthcare, Novartis, Glenmark Pharmaceuticals, Sun Pharma, Teva, and Sandoz

Pesticide outcry stalls House farm bill

Farm bill's pesticide labeling clause spurs bipartisan pushback | Agri-Pulse Communications, Inc.

US Supreme Court hears Bayer's fight against Roundup lawsuits

Supreme Court weighs future of Roundup lawsuits - CBS Miami

Supreme Court heard case about labels for Bayer's Roundup : NPR

With Bayer at US Supreme Court, MAHA rallies against pesticides

Pesticide labeling front and center at Supreme Court

Bayer Faces Legal Challenge Over Roundup Liability

Supreme Court divided on Roundup cancer lawsuits

US Supreme Court hears Bayer bid to end Roundup weedkiller suits | Hindustan Times

SCOTUS Mixed on Bayer Effort to Corral Roundup Suits: The Brief

Bayer Gets Mixed Reception From Supreme Court on Roundup Suits

Bayer AG asks Court to shut down lawsuits over Roundup cancer risk

MAHA Advocates To Converge In Washington For 'People Vs. Poison' Rally

Bayer Faces Supreme Court Hearing on Roundup Liability

Protesters come out against weed killer in Supreme Court case

US supreme court to hear case that could weaken consumers' ability to sue for failure to warn of product risks

MAHA is mad. Its alliance with Trump is about to face its biggest test

A Supreme Court case over pesticides is bringing out the ���MAHA moms��� ��� and threats of consequences for the midterms

Bayer Aktiengesellschaft AGM: CFO Transition, 2026 Outlook, and Roundup Litigation Update - Daily Political

Washington Week Ahead: Farm bill and Roundup on tap as ag woes mount

Bayer gets mixed reception at Supreme Court on Roundup suits | Business News « ArcaMax Publishing